Agrochemical Stock Hits 5% Upper Circuit After Vijay Kedia Increases Stake in the Co.

Synopsis: Vijay Kishanlal Kedia’s firm, Kedia Securities Private Limited, increased its stake in Mahamaya Lifesciences Limited to 4.53% after multiple share purchases, signalling strong investment confidence.

This Micro-cap Agrochemicals Stock, engaged in manufacturing, registering, and exporting agrochemical products, including pesticide formulations and bioproducts, aimed at improving crop yield and soil health, hit a 5 percent upper circuit after ace investor Vijay Kishanlal Kedia increased his stake of 4.53 percent in the company

With a market capitalization of Rs. 363.71 crores, the shares of Mahamaya Lifesciences Limited hit a 5 percent upper circuit of Rs. 155.40 per share on Friday, up from its previous closing price of Rs. 148 per share.

Reason Behind the Surge

Ace Investor Vijay Kishanlal Kedia’s firm, Kedia Securities Private Limited, has increased its stake in Mahamaya Lifesciences Limited through recent market transactions. The firm acquired 1.69 lakh shares, representing a 0.72 percent stake, at an average price of ₹146.36 per share, amounting to approximately ₹2.48 crore.

Earlier, before December 16, the firm had purchased around 8.92 lakh shares at an average price of ₹140 per share, with a total investment of about ₹12.48 crore. Following these acquisitions, Kedia Securities has strengthened its position in the company, now holding a total stake of 4.53 percent, reflecting continued confidence in the company’s growth prospects.

In the shareholding pattern, Mahamaya Lifesciences Limited had a majority stake held by the promoters at 56.35 percent, foreign institutional investors at 6.39 percent, domestic institutional investors at 4.67 percent, and the public at 32.30 percent in November 2025.

IPO Information

Mahamaya Lifesciences Limited launched its Initial Public Offering (IPO) from November 11 to 13, 2025, aiming to raise about Rs. 70.44 crore through a mix of fresh issue and offer for sale. The fresh issue comprised 0.56 crore shares worth Rs. 64.28 crore, while the offer for sale included 0.05 crore shares aggregating to Rs. 6.16 crore.

This move is part of the company’s strategy to fund equipment purchases for its existing formulation plant, invest in a new technical manufacturing facility, build a warehouse, acquire machinery, meet working capital needs, and support general corporate purposes.

Company Overview

Mahamaya Lifesciences Limited was incorporated in 2002 and is an agrochemical company engaged in the manufacturing, registration, and export of crop protection products and bioproducts. The company focuses on enhancing crop yield and soil health by providing effective agricultural solutions to farmers. Its operations support improved productivity through scientifically developed inputs tailored for modern farming needs.

The company specializes in pesticide formulations and bulk agrochemical supplies, serving both domestic firms and multinational corporations. It imports researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added products. With a presence in international markets including Egypt, UAE, and Turkey, Mahamaya Lifesciences offers a diverse portfolio spanning bulk for

Recent Quarter Results

Coming into financial highlights, Mahamaya Lifesciences Limited’s revenue has increased from Rs. 146 crore in H1 FY25 to Rs. 163 crore in H1 FY26, which has grown by 11.64 percent. The net profit has also grown by 14.29 percent from Rs. 7 crore in H1 FY25 to Rs. 8 crore in H1 FY26. Mahamaya Lifesciences Limited’s revenue and net profit have grown at a CAGR of 43.15 percent and 63.03 percent, respectively, over the last three years.

In terms of return ratios, the company’s ROCE and ROE stand at 25.9 percent and 34.9 percent, respectively. Mahamaya Lifesciences Limited has an earnings per share (EPS) of Rs. 7.28, and its debt-to-equity ratio is 1.18x.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Agrochemical Stock Hits 5% Upper Circuit After Vijay Kedia Increases Stake in the Co. appeared first on Trade Brains.